July/August 2025

NEWS & COLUMNS

6-7 NEWS
AstraZeneca and CSPC in AI deal worth $5.3bn; Roche’s Evrysdi approved by EC for SMA

8-9 NEWS
Eli Lilly’s once-weekly insulin shows promise; FDA unveils priority review programme

10-11 DERMATOLOGY NEWS
Boehringer’s Spevigo recommended by NICE; UCB’s Bimzelx shows lasting efficacy in PsA

12 DARWIN'S MEDICINE
Motivating low-performance teams

13 TRUST AND TRENDS
We must tailor our messaging rationally and emotionally

14 INNOVATIVE IMPACT
Pharma's most underrated capability

15 EMPATHY IS NOT A SOFT SKILL
It needs to be a strategic anchor

FEATURES

16-17 CELEBRATING THE CANNES LIONS INTERNATIONAL FESTIVAL OF CREATIVITY
Cannes’ most forward-looking conversations weren’t about pharma – but pharma should have been listening. Why brands need to move beyond standard product promotion and toward the curation of memorable interactions

20-21 IMPROVING TRANSPARENCY AND TRACEABILITY WITHIN THE SUPPLY CHAIN’S FIRST MILE
Full supply chain visibility can help manufacturers respond more efficiently to supply and demand changes – how manufacturers can implement processes to help improve this critical part of the supply chain

22-23 ARE BOTANICAL DRUGS PART OF THE FUTURE OF MEDICINE?
Botanical drugs are stepping into the space between traditional remedies and modern pharmaceuticals